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Moderate Prenatal Cadmium Exposure and Adverse Birth
Outcomes: a Role for Sex-Speciﬁc Differences?
Caroline M. Taylor, Jean Golding, Alan M. Emond
Centre for Child and Adolescent Health, School of Social and Community Medicine, University of Bristol, Bristol, UK
Abstract
Background/Aim: Studies on the effects of moderate prenatal exposure to cadmium (Cd) on birth outcomes have
been contradictory and it has been suggested that effects may be partly masked by sex-specific effects. Our aim
was to examine the association of Cd exposure in a large group of pregnant women with birth outcomes in the
whole group of participants and by sex.
Methods: Pregnant women were enrolled in the Avon Longitudinal Study of Parents and Children (ALSPAC).
Whole blood samples for singleton pregnancies with a live birth were analysed for Cd (n = 4191). Data collected
on the infants included anthropometric variables and gestational age at delivery. Data were analysed using SPSS
v18.
Results: There were adverse associations of maternal blood Cd level with birthweight (unstandardized B
coefficient 62.7 g, 95% CI 107.0, 18.4) and crown–heel length (0.28 cm, 95% CI 0.48, 0.07) in adjusted
regression models. On stratification by sex, maternal blood Cd level was adversely associated with birthweight
(87.1 g, 95% CI 144.8, 29.4), head circumference (0.22 cm, 95% CI 0.39, 0.04), and crown–heel length
(0.44 cm, 95% CI 0.71, 0.18) in girls but not in boys in adjusted regression models.
Conclusion: In these pregnant women with moderate prenatal Cd exposure there evidence of adverse associations
with birth anthropometry variables in the whole group. However, there was evidence of associations with
anthropometric variables in girls that were not evident in boys. Sex-specific effects require further investigation in
large cohorts as a possible contributor to the lack of associations generally found in mixed-sex studies.
Keywords: ALSPAC, cadmium, pregnancy, environment, smoking, child, birth outcomes, heavy metals.
Cadmium (Cd) is a non-essential cumulative toxic
metal that is widespread in the environment. Occupa-
tional exposure is generally associated with battery
manufacture and recycling, and non-occupational
exposure arises through fossil fuel combustion, waste
incineration, and manufacturing processes including
those for cement, iron, and steel. Smoking tobacco,
however, is the most important source of Cd in the
general population: cigarettes contain about 0.5–
1.5 lg Cd/cigarette, with 20–50% of this transferred
directly to the circulation.1 For non-smokers, the pri-
mary source of exposure is through diet, with grains
and grain products, vegetables and vegetable prod-
ucts, and starchy roots and tubers making the greatest
contributions to total ingestion (27%, 16%, and 13%,
respectively).2 Cd absorption may be dependent on
micronutrient status, particularly calcium, zinc, and
iron.3
Adverse health effects from Cd exposure include
kidney, breast, prostate, and lung cancer; cardiovascu-
lar disease; and osteoporosis. These diseases may be
related to the role of Cd as an endocrine disruptor
through interaction with hormone signalling path-
ways.4 Its effects on birth outcomes, however, particu-
larly at moderate exposures, are not well understood
and in this regard Cd has received far less research
attention than its near neighbours in the periodic
table, lead and mercury, The placenta is thought to be
at least a partial barrier to Cd transfer to the fetus,5,6
but determination of ratios of Cd in cord blood :
maternal blood have left this in doubt (ratios ranging
from 0.247 to 1.08,8 with others finding intermediate
values9,10). Studies with moderate maternal blood
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cadmium levels (B-Cd; below a suggested reference
value of 1 lg/L11) and adjustment for smoking have
generally found no associations with birthweight,
birth length, head circumference or preterm deliv-
ery,8,12,13 but other studies have found negative asso-
ciations particularly with birthweight14–16 (Table S1).
Even where exposure levels are higher and effects
could potentially be more evident, again some studies
have found no associations with birth outcomes,10,17
while others have found adverse associations.18 It has
recently been suggested that adverse events associ-
ated with maternal Cd exposure are sex-specific, with
effects on birthweight and birth length being more
severe in or confined to girls8, 19–21 and that this might
mask effects in mixed-sex studies.
The aims of this study were: (1) to evaluate the
effect of moderate prenatal exposure to Cd on a range
of birth outcomes (birthweight, head circumference,
crown–heel length, preterm delivery, and low birth-
weight) independently of active and passive smoking
status in a large cohort of pregnant women, (2) to
evaluate sex-specific effects of maternal Cd exposure
on these birth outcomes.
Methods
The ALSPAC study
The sample was derived from the ALSPAC study, a
population-based study investigating environmental
and genetic influences on the health, behaviour, and
development of children. This database provided an
opportunity to include a large number of participants
and includes a wide range of social and demographic
information to enable the most appropriate selection
of covariates. All pregnant women in the former Avon
Health Authority with an expected delivery date
between April 1991 and December 1992 were eligible
for the study; 14 541 pregnant women were enrolled,
resulting in a cohort of 14 062 live births. The social
and demographic characteristics of this cohort were
similar to those found in UK national census surveys.
Further details of ALSPAC are available at www.bri-
s.ac.uk/alspac and the study website contains details
of all the data that are available through a fully
searchable data dictionary (http://www.bris.ac.
uk/alspac/researchers/data-access/data-dictionary).
Ethics approval for the study was obtained from the
ALSPAC Ethics and Law Committee and the Local
Research Ethics Committees.
Collection, storage, and analysis of blood samples
Whole blood samples were collected in acid-washed
vacutainers (Becton and Dickinson, Oxford, UK) by
midwives as early as possible in pregnancy (median
of 11 weeks’ gestation (IQR 9–13 weeks) with a mode
of 10 weeks). Whole blood samples were stored in
the original tube at 4°C at the collection site before
being transferred to the central Bristol laboratory
within 1–4 days. Samples were at ambient tempera-
ture during transfer (up to 3 h). They were then
stored at 4°C until analysis. Details of the analysis
have been reported.22 In brief, inductively coupled
plasma mass spectrometry in standard mode (R.
Jones, Centers for Disease Control and Prevention
(CDC), Bethesda, MD, USA CDC; Method 3009.1)
was used to measure blood levels of Cd with appro-
priate quality controls. The analyses were completed
for 4484 women for Cd. 1119 samples had a Cd level
below the limit of detection (0.2 lg/L): these were
assigned a value of 0.14 lg/L (LOD/√2) to reflect the
log-normal distribution.23
Pregnancy outcomes
Newborn head circumference and crown–heel length
were measured by trained study staff where the
mother gave permission, or if these data were miss-
ing, the values were extracted from the medical
records by trained study staff. Birthweight was
derived from obstetric data and from central birth
notification data: where values disagreed by <100 g
then the lowest value was accepted; if the values dis-
agreed by >100 g then the value was coded as miss-
ing. Study staff were blinded to the maternal blood
Cd. Length of gestation was based on last menstrual
period date, ultrasound assessment or other clinical
indicators. Where there was conflict of ≥14 days
between the maternal report and ultrasound assess-
ment, an experienced obstetrician reviewed the
clinical records and made a best estimate. Low birth-
weight (LBW) was defined as birthweight <2500 g
and preterm birth as <37 weeks gestation.
Questionnaires
The mothers received four postal self-completion ques-
tionnaires during pregnancy. The questionnaires are
available from the study website (http://www.bristol.
ac.uk/alspac/researchers/questionnaires/).
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Information collected on environmental and life
style factors from questionnaires during pregnancy
included data on age, parity, social class, highest edu-
cational qualification, alcohol consumption, cigarette
smoking, etc. Data on cigarette smoking were taken
from a questionnaire completed at enrolment at gesta-
tion ≤14 weeks in response to a question on the num-
ber of cigarettes smoked in the previous 2 weeks
(categorized as yes/no) and on whether the partner
smoked (yes/no). If gestation was >14 weeks at enrol-
ment, the questionnaire was completed 4–7 weeks
after enrolment.
Statistical analysis
Participants were excluded from the study if they did
not have a singleton live birth (see Figure S1 for study
flow chart). Statistical analysis was done with SPSS
version 23 (IBM Corp., Chicago, IL, USA). Values are
reported as meanSD. Chi-square tests were used to
analyse differences in categorical data, and ANOVA
was used to compare continuous values by tertiles of
B-Cd.
The main analyses were conducted for term
deliveries only (≥37 weeks). Additional analyses
were conducted for all gestational ages (results
shown in supporting information Tables). Univari-
ate and multivariable linear regression models were
used to examine the relationship of B-Cd with
birthweight, head circumference, and crown–heel
length. Logistic regression analysis was used to
examine the effect of the binary outcome variable
LBW (<2500 g) by tertiles of maternal B-Cd (the
binary outcome preterm birth <37 weeks was also
included in analyses of the group including all ges-
tational ages). Model 1 included the following con-
founders: maternal age, maternal height, maternal
pre-pregnancy body mass index, maternal educa-
tional attainment, parity (0 versus ≥1), alcohol con-
sumption (number of units per week), and sex of
the baby. These factors were chosen as being con-
sistently associated with birthweight, length of ges-
tation, and fetal growth retardation as well as other
measures including low birthweight, preterm
delivery, and small-for-gestational-age (SGA) at
birth as well as B-Cd. We did not include maternal
ethnicity in any of the models because of the low
numbers of ethnic minority participants included in
the sample (non-white 2.4%). Model 2 also included
maternal smoking (yes/no); partner smoking (yes/
no) was added for model 3. Gestational age was not
included as a confounder in the association between
prenatal exposure and birth outcome as it is consid-
ered to be a collider in the association between envi-
ronmental exposure and birth outcomes, and could
therefore mask associations.24 To address this we
excluded preterm births from the main analyses;
however, the effect of gestational age was assessed as
an additional confounder to model 3 for the whole
group (results shown in supporting information
Tables).
We undertook three further analyses. (1) Since there
was collinearity between smoking and B-Cd, models
1–3 for all births were repeated after stratification for
smokers and non-smokers. (2) The mediating effect of
Cd in the association between smoking and anthropo-
metric outcomes was assessed with models of the
associations with and without adjustment for the
maternal B-Cd level. (3) Sex-specific effects of mater-
nal B-Cd were evaluated by repeating models 1–3 for
all births after stratification by the sex of the offspring.
Regression diagnostics were used to check that
the models fitted the observed data well and to
identify any cases that had undue influence on the
model.
Results
Characteristics of mothers and offspring
There were 4191 singleton livebirths included in the
study, of which 3838 were a term birth and were
included in the main analyses. Mothers with data on
B-Cd were broadly similar to those without, except
that they had a higher educational attainment and
were slight older.22 The characteristics of the mothers
are shown in Table S2.
The mean maternal B-Cd level was 0.56  0.62
(range 0.14–6.30) (median 0.29, interquartile range
0.14–0.68) lg/L. As reported previously, the mean
B-Cd level was similar to those reported in other
developed countries.25 The mean B-Cd level in
smokers was 77% greater than in non-smokers and
increased with the number of cigarettes smoked
(Table S3). Levels were also greater in mothers
whose partners smoked (Table S3) (22% greater for
non-smoking mothers whose partners smoked and
79% greater if both mother and partner were
smokers compared with both non-smokers;
P < 0.001).
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Regression models for B-Cd and birth outcomes
In univariate analyses with tertiles of B-Cd, there was
strong evidence for negative associations of maternal
B-Cd with birthweight, head circumference, and
crown–heel length (all P ≤ 0.001; Table 1). The unad-
justed models predicted reductions of 133 g in birth-
weight, 2 mm in head circumference, and 6 mm in
crown–heel length with each 1 lg/L increase in
maternal B-Cd (Table 2). These associations were
maintained with adjustment for maternal educational
attainment, age, parity, pre-pregnancy BMI, height,
and alcohol intake, and sex of the baby (model 1).
When maternal smoking was included, the strong
associations for birthweight and crown–heel length
were maintained (model 2), but the association for
head circumference was slightly attenuated. Addi-
tional adjustment for partner smoking status did not
alter the outcomes of model 2 greatly (slight attenua-
tion) (model 3). The results were broadly similar when
preterm births were included (Tables S4 and S5).
Adjustment for gestational age attenuated the associa-
tions of maternal B-Cd with the anthropometric
variables (Table S5).
Univariate logistic regression analysis showed no
association across tertiles of maternal B-Cd with
decreasing odds of LBW (Table 3), but there was evi-
dence of an association when preterm births were
included (Table S5). There was no evidence for a uni-
variate association between maternal B-Cd and pre-
term delivery in the whole group (Table S6).
Adjustment to the univariate models (models 1–3) did
not show evidence for any associations between
maternal B-Cd and the odds of LBW in the group with
term deliveries only (Table 3) or in the group with all
births (Table S6).
Regression models for B-Cd and birth outcomes
stratiﬁed by smoking status
Repetition of all the models for mothers stratified
into smokers and non-smokers did not provide any
evidence for any associations of maternal B-Cd
with birth outcomes in non-smokers. In smokers
there was evidence of a weak adverse association
with birthweight for the group with term births
only and for the group including all gestational
ages that was not evident in non-smokers (Tables
S7 and S8).
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Mediation of Cd in the association between smoking
status and birth outcomes
There were strong associations between maternal
smoking and anthropometric outcomes (birthweight,
head circumference, crown–heel length) in adjusted
linear regression models (Table 4) for the main
group with no preterm births. The unadjusted
models predicted decreases of 171 g in birthweight,
3 mm in head circumference, and 6 mm in crown–
heel length for smokers compared with non-smokers.
These associations were not greatly attenuated when
maternal B-Cd was included in the models for birth-
weight and head circumference, indicating that
maternal B-Cd was not a strong mediator in the
association between smoking and anthropometric
birth outcomes, although for crown–heel length the
association was more attenuated with the inclusion
of B-Cd in the model. There were no associations
between smoking and LBW. The results in the whole
group including all gestational ages were similar
(Table S9).
Sex-speciﬁc effects of maternal B-Cd on birth
outcomes
On stratification by sex, birthweight, head circumfer-
ence, and crown–heel length were significantly
adversely associated with maternal B-Cd in girls but
not in boys in adjusted models (Table 5). The interac-
tion term sex 9 maternal B-Cd was significant for all
anthropometric variables. The results in the whole
group were similar (Table S10)
Comments
There was evidence of associations between moderate
maternal B-Cd level and some birth outcomes (birth-
weight, crown–heel length) but not with others (head
circumference, low birthweight) in adjusted regres-
sion models in a large cohort of women. However, on
stratification by sex there were significant adverse
associations between maternal B-Cd and birthweight,
Table 2. Associations of maternal B-Cd with birth outcomes in
ALSPAC (linear regressions)
n R2
Unstandardized B
coefficient (95% CI)
Birthweight
Unadjusted 3778 0.029 133.4 (158.2, 108.6)
Model 1 2709 0.149 116.0 (146.6, 85.4)
Model 2 2707 0.152 72.0 (114.0, 30.1)
Model 3 2578 0.150 62.7 (107.0, 18.4)
Head circumference
Unadjusted 3313 0.011 0.22 (0.29, 0.15)
Model 1 2400 0.133 0.19 (0.27, 0.10)
Model 2 2398 0.134 0.10 (0.23, 0.19)
Model 3 2289 0.137 0.09 (0.22, 0.04)
Crown–heel length
Unadjusted 3277 0.025 0.55 (0.66, 0.43)
Model 1 2375 0.145 0.42 (0.56, 0.28)
Model 2 2373 0.146 0.31 (0.50, 0.11)
Model 3 2266 0.148 0.28 (0.48, 0.07)
Live singleton births, gestational age ≥37 weeks.
Model 1: Adjusted for maternal education, maternal age, parity,
sex of baby, maternal BMI, maternal height, maternal alcohol
intake.
Model 2: Adjusted as for Model 1 + maternal smoking
(yes/no).
Model 3: Adjusted as for Model 2 + partner smoking (yes/no).
Table 3. Associations of tertiles of maternal B-Cd with birth outcomes in ALSPAC (logistic regressions)
n R2 a
OR (95% CI)
P for trendT1 T2 T3
LBW
Unadjusted 3788 0.001 Ref 1.34 (0.72, 2.51) 0.78 (0.45, 1.37) 0.348
Model 1 2709 0.009 Ref 1.37 (0.66, 2.82) 0.93 (0.66, 2.82) 0.856
Model 2 2707 0.010 Ref 1.38 (0.67, 2.89) 1.39 (0.54, 3.60) 0.399
Model 3 2580 0.009 Ref 1.36 (0.66, 2.80) 0.93 (0.46. 1.89) 0.414
Live singleton births, gestational age ≥37 weeks.
Model 1: Adjusted for maternal age, maternal education, parity, sex of baby, maternal BMI, maternal height, maternal alcohol intake.
Model 2: Adjusted as for Model 1 + maternal smoking (yes/no).
Model 3: Adjusted as for Model 2 + partner smoking (yes/no).
aCox and Snell pseudo R2.
© 2016 The Authors. Paediatric and Perinatal Epidemiology Published by John Wiley & Sons Ltd.
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head circumference, and crown–heel length in girls
but not in boys. Although maternal B-Cd was associ-
ated linearly with an increase in the number of cigar-
ettes smoked per day, with an additional effect of
partner smoking, in univariate analysis, there was no
evidence that B-Cd levels in either smokers or in non-
smokers were associated with adverse birth outcomes.
There was no evidence that maternal B-Cd mediated
adverse associations between smoking and birth out-
comes.
The mechanisms for the putative effects of Cd on
birth outcomes may be related directly to toxic effects
on the fetus and/or mediated through toxic effects
within the placenta. Although the placenta may act as
a partial barrier to Cd being transferred to the fetus, it
is likely that at least some Cd accumulates in the pla-
centa.26 There it can act as a barrier to the transfer of
micronutrients, particularly zinc, by induction of met-
allothionein production,3 and this could restrict fetal
growth directly. Cd may also have oestrogenic endo-
crine disrupting effects,4 which could restrict the
expression of placental genes linked to growth and
development (for example, 11b-HSD2 and 3b-HSD,
which control the transfer of glucocorticoids to the
Table 4. Mediation of maternal B-Cd in associations between smoking and birth outcomes in ALSPAC
n R2a
Birthweight (g) Unstandardized B coefficient (95% CI)
Model without adjustment for Cd 2578 0.148 171.2 (221.0, 121.0)
Model with adjustment for Cd 2578 0.150 108.9 (175.6, 42.2)
Head circumference (cm)
Model without adjustment for Cd 2289 0.137 0.30 (0.45, 0.16)
Model with adjustment for Cd 2289 0.137 0.21 (0.41, 0.02)
Crown–heel length (cm)
Model without adjustment for Cd 2266 0.146 0.59 (0.82, 0.35)
Model with adjustment for Cd 2266 0.148 0.31 (0.62, 0.01)
LBW OR (95% CI)
Model without adjustment for Cd 2578 0.010 1.61 (0.77, 3.39)
Model with adjustment for Cd 2578 0.010 1.66 (0.62, 4.39)
Live singleton births, gestational age ≥37 weeks.
Smoking (exposure) (yes/no), birth outcome (outcome), maternal Cd (mediator).
Models adjusted for maternal age, maternal education, sex of baby, parity, maternal BMI, maternal height, maternal alcohol intake,
maternal smoking (yes/no), paternal smoking (yes/no).
aCox and Snell pseudo R2.
Table 5. Sex-specific differences in birth outcomes in association with maternal B-Cd levels in ALSPAC
N R2a Unstandardized B coefficient (95% CI)
P for interaction sex
9 maternal B-Cd
Birthweight (g)
Girls 1274 0.131 87.1 (144.8, 29.4) <0.001
Boys 1304 0.143 30.8 (98.6, 37.0)
Head circumference (cm)
Girls 1151 0.067 0.22 (0.39, 0.04) <0.001
Boys 1138 0.081 0.05 (0.14, 0.24)
Crown–heel length (cm)
Girls 1141 0.132 0.44 (0.71, 0.18) <0.001
Boys 1125 0.118 0.07 (0.38, 0.25)
Live singleton births, gestational age ≥37 weeks.
Models adjusted for maternal age, maternal education, parity, maternal BMI, maternal height, maternal alcohol intake, maternal
smoking (yes/no), paternal smoking (yes/no).
aCox and Snell pseudo R2.
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fetus27). Finally, Cd can act as an epigenic modifier.28
These mechanisms suggest that Cd could influence
long-term child developmental outcomes.
Despite these theoretical effects, the evidence from
epidemiological studies for negative associations of
maternal Cd status with birth outcomes, particularly
for outcomes other than birthweight, is mixed. With
regard to birthweight, the results of studies of associa-
tions with maternal or cord blood Cd and have been
conflicting. In the largest study to date, Wang et al.29
found an adverse association of maternal serum Cd
with the baby being SGA in 3254 non-smoking
mother–infant pairs in China, with mothers with
serum Cd ≥1.06 lg/L being 43% more likely to have
an SGA infant than those with levels <1.06 lg/L in
adjusted models. Other studies have found adverse
associations of maternal B-Cd with SGA and/or
birthweight in models adjusted for smoking.14–16
Conversely, other studies have found no associa-
tions7,9,12,30 or even beneficial associations31 with
birthweight or SGA in models adjusted or stratified
for smoking, even when mean or median maternal B-
Cd levels were high (>1 lg/L).10,32,33 There is greater
consensus for other birth outcomes (birth length or
crown–heel length, head circumference, gestational
age, preterm birth), with most studies finding no asso-
ciations (see Table S5). Studies using tissues other
than maternal blood or cord blood to assess Cd status,
such as urine, hair or placental tissue are rather more
difficult to interpret, but findings are broadly simi-
lar, with most studies finding no associations with
birth outcomes (see Table S1). Where they exist, dif-
ferences in the findings of studies could be
accounted for, for example, by differences in the
confounders that the models include, between-coun-
try differences in health services, or differences in
the way in which data on smoking were collected
or categorized. Measurement of blood or urine coti-
nine may be a useful way of measuring smoking
exposure in this context15 in future studies. In addi-
tion, some studies on maternal and/or cord blood
Cd levels and birth outcomes have been limited by
a small sample size (see Table S1).
To our knowledge, only one previous study has
stratified the data by smoking status: Menai et al.34
found an adverse association of maternal B-Cd with
birthweight in smokers but not in non-smokers, in
accordance with our findings. This could be inter-
preted as a differential effect reflecting higher Cd
levels in smokers.
It is possible that associations of birth outcomes
with maternal B-Cd in mixed-sex groups could be
masked by opposing effects in female and male off-
spring. It has been suggested that associations, par-
ticularly with anthropometric variables, tend to be
adverse in girls but beneficial in boys, as was sug-
gested in the present study for head circumference
and crown–heel length. This was first proposed by
Kippler et al.20,21 in a cohort in Bangladesh and has
subsequently been replicated in cohorts from South
Africa and the USA.8,19 Kippler et al.20 suggested
several mechanisms for this differential effect: (1)
the relative sensitivity of female fetuses compared
with male fetuses to a Cd-induced increase in glu-
cocorticoid concentrations reflecting a decrease
in 11b-HSD2 activity, with a consequent increase in
cortisol level; (2) differential Cd interference with
the IGF axis, as there is some evidence that levels
of IGF subtypes are sex-specific; (3) the male skele-
ton may be more resistant to Cd-induced bone
damage through differential effects on bone miner-
alization, bone density, and bone mineral content;
(4) there may be effects on in utero sex-specific pro-
gramming that contribute to the vulnerability of the
fetus to environmental stressors. As suggested by
Rollin et al.8 these effects may be related to
hypomethylation of growth-related genes in girls
relative to hypermethylation in boys in response to
Cd exposure.35
This study has a number of strengths. (1) The study
involved a large number of pregnant women with
both prenatal B-Cd and birth outcomes. (2) The prena-
tal exposure was B-Cd measured in the first half of
pregnancy, in contrast to studies that have relied on
cord blood Cd or Cd in other matrices such as hair or
urine. (3) The data on maternal smoking were well
characterized. (4) We were able to include data on
passive smoking. (5) We were able to differentiate
effects in female offspring from male offspring. There
are some limitations to the study. (1) Although we
were able to account for many possible confounders
in our analyses, there are likely to be others that were
unable to adjust for. These include the effects of other
environmental pollutants, such as polychlorinated
biphenols.26 (2) There were a large number of values
for B-Cd below the limit of detection, making the use
of the measurement as a continuous variable in linear
models less robust. However, we used a well docu-
mented means of correcting values below the limit of
detection.
© 2016 The Authors. Paediatric and Perinatal Epidemiology Published by John Wiley & Sons Ltd.
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Conclusion
In accordance with putative mechanisms of the toxic
effects of Cd on birth outcomes, we found evidence
for independent associations of maternal B-Cd level
with birthweight and crown–heel length in adjusted
linear regression models, but not with head circumfer-
ence. There was no evidence of an increased odds of
having a low birthweight baby in adjusted logistic
regression models. When the models were repeated
after stratification into smokers and non-smokers,
there was evidence for an adverse association with
birthweight in smokers. Maternal B-Cd was not a
strong mediator in the associations between smoking
and any of the pregnancy outcomes. However, there
was strong evidence of differential effects in female
and male offspring on anthropometric variables (sig-
nificant adverse associations of maternal B-Cd with
birthweight, head circumference, and crown–heel
length in girls but not in boys). We conclude that sex-
specific effects require further investigation as a possi-
ble contributor to the lack of associations found in
most mixed-sex studies.
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